Guillaumond, F., Bidaut, G., Ouaissi, M., Servais, S., Gouirand, V., Olivares, O., . . . Vasseur, S. (2015). Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proc Natl Acad Sci U S A.
シカゴスタイル引用形Guillaumond, Fabienne, et al. "Cholesterol Uptake Disruption, in Association With Chemotherapy, Is a Promising Combined Metabolic Therapy for Pancreatic Adenocarcinoma." Proc Natl Acad Sci U S A 2015.
MLA引用形式Guillaumond, Fabienne, et al. "Cholesterol Uptake Disruption, in Association With Chemotherapy, Is a Promising Combined Metabolic Therapy for Pancreatic Adenocarcinoma." Proc Natl Acad Sci U S A 2015.
警告: この引用は必ずしも正確ではありません.